lifestyle.newsblaze.com

Author: Arch Biopartners

Arch Biopartners Closes Non-Brokered Private Placement

April 2, 2026
Arch Biopartners Arranges Non-Brokered Private Placement

March 30, 2026
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial

March 24, 2026
Arch Biopartners Announces St. Michael’s Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide

March 20, 2026
Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease

February 12, 2026